this rose to 200m mc, on the initiation of its phase 1 trials.
It doesnt need sales to be launched to multiples. It needs the market to again be displaced by those who take an appetite to the foot print it will leave in the medical diagnostic landscape, and that is measured in multitudes of billions.
- Forums
- ASX - By Stock
- Ann: Imagion presents ovarian cancer data at AACR conference
IBX
imagion biosystems limited
Add to My Watchlist
11.1%
!
1.6¢

this rose to 200m mc, on the initiation of its phase 1 trials.It...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
-0.002(11.1%) |
Mkt cap ! $3.221M |
Open | High | Low | Value | Volume |
1.8¢ | 1.8¢ | 1.6¢ | $35.73K | 2.076M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 2882348 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 992206 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 2882348 | 0.016 |
13 | 1595671 | 0.015 |
11 | 2811002 | 0.014 |
13 | 1902142 | 0.013 |
20 | 4925863 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 992206 | 2 |
0.018 | 584048 | 7 |
0.019 | 2759109 | 11 |
0.020 | 2763606 | 14 |
0.021 | 1858857 | 4 |
Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |